Advertisement

Topics

GSK’s former chief Witty makes surprise move to ‘the dark side’

06:48 EDT 14 Mar 2018 | pharmaphorum

GlaxoSmithKline’s (GSK) former chief executive Andrew Witty was yesterday announced as the new CEO of Optum – a US payer organisation which includes pharmacy benefits manager OptumRx. Witty, who handed over to Emma Walmsley a year ago at GSK, had ...

Original Article: GSK’s former chief Witty makes surprise move to ‘the dark side’

NEXT ARTICLE

More From BioPortfolio on "GSK’s former chief Witty makes surprise move to ‘the dark side’"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

GlaxoSmithKline
GlaxoSmithKline is the third largest pharmaceutical company in the world, based on annual sales, which reached $37,134m in 2009. Spread over 100 countries, GSK employs 96,500 people, 13,000 of which are dedicated to research and development of the the ...

Biotechnology Business
Alliances Astrazeneca Bioethics Boehringer Clinical Research Organization Collaborations GSK Johnson & Johnson Lilly Merck Mergers and Acquisitions Nexium Novartis Pfizer Roche Sanofi ...

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...